Cargando…

Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]

BACKGROUND: This study was designed to determine if a natural mineral supplement, sierrasil, alone and in combination with a cat's claw extract (Uncaria guianensis), vincaria, has therapeutic potential in mild to moderate osteoarthritis of the knee. METHODS: Patients (n = 107) with mild to mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Mark JS, Mehta, Komal, Kunte, Sameer, Raut, Vidyanand, Gala, Jayesh, Dhumale, Ramesh, Shukla, Anil, Tupalli, Hemant, Parikh, Himanshu, Bobrowski, Paul, Chaudhary, Jayesh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1276811/
https://www.ncbi.nlm.nih.gov/pubmed/16242032
http://dx.doi.org/10.1186/1476-9255-2-11
_version_ 1782126012730966016
author Miller, Mark JS
Mehta, Komal
Kunte, Sameer
Raut, Vidyanand
Gala, Jayesh
Dhumale, Ramesh
Shukla, Anil
Tupalli, Hemant
Parikh, Himanshu
Bobrowski, Paul
Chaudhary, Jayesh
author_facet Miller, Mark JS
Mehta, Komal
Kunte, Sameer
Raut, Vidyanand
Gala, Jayesh
Dhumale, Ramesh
Shukla, Anil
Tupalli, Hemant
Parikh, Himanshu
Bobrowski, Paul
Chaudhary, Jayesh
author_sort Miller, Mark JS
collection PubMed
description BACKGROUND: This study was designed to determine if a natural mineral supplement, sierrasil, alone and in combination with a cat's claw extract (Uncaria guianensis), vincaria, has therapeutic potential in mild to moderate osteoarthritis of the knee. METHODS: Patients (n = 107) with mild to moderate osteoarthritis of the knee were randomly assigned to one of 4 groups; high dose sierrasil (3 g/day), low dose sierrasil (2 g/day), low dose sierrasil (2 g/day) + cat's claw extract (100 mg/day) or placebo, administered for 8 weeks. Treatment was double blinded. Primary efficacy variables were WOMAC scores (A, B, C and total). Visual analog score (VAS) for pain, consumption of rescue medication (paracetamol), and tolerability were secondary variables. Safety measures included vital signs and laboratory-based assays. RESULTS: Ninety-one of the 107 patients successfully completed the protocol. All four groups showed improvement in WOMAC and VAS scores after 8 weeks (p < 0.001), in all 3 groups receiving sierrasil the magnitude of benefits were greater vs. placebo (WOMAC Total 38–43% vs. 27%) but this was not statistically significant. In reference to baseline values sierrasil treated groups had a considerably faster onset of benefits. Placebo-treated individuals failed to show significant benefits at 4 weeks (11% reduction in total WOMAC). In contrast, after 1 or 2 weeks of therapy all the sierrasil groups displayed significant reductions in WOMAC scores (p < 0.05) and at week 4 displayed a 38–43% improvement. VAS was significantly improved at 4 weeks in all groups (p < 0.001) but was significantly greater in all sierrasil groups compared to placebo (p < 0.05). Rescue medication use was 28-23% lower in the herbomineral combination and high dose sierrasil groups although not statistically different from placebo (P = 0.101 and P = 0.193, respectively). Tolerability was good for all groups, no serious adverse events were noted and safety parameters remained unchanged. CONCLUSION: The natural mineral supplement, sierrasil alone and in combination with a cat's claw extract, improved joint health and function within 1–2 weeks of treatment but significant benefits over placebo were not sustained, possibly due to rescue medication masking. Sierrasil may offer an alternative therapy in subjects with joint pain and dysfunction.
format Text
id pubmed-1276811
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12768112005-11-03 Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711] Miller, Mark JS Mehta, Komal Kunte, Sameer Raut, Vidyanand Gala, Jayesh Dhumale, Ramesh Shukla, Anil Tupalli, Hemant Parikh, Himanshu Bobrowski, Paul Chaudhary, Jayesh J Inflamm (Lond) Research BACKGROUND: This study was designed to determine if a natural mineral supplement, sierrasil, alone and in combination with a cat's claw extract (Uncaria guianensis), vincaria, has therapeutic potential in mild to moderate osteoarthritis of the knee. METHODS: Patients (n = 107) with mild to moderate osteoarthritis of the knee were randomly assigned to one of 4 groups; high dose sierrasil (3 g/day), low dose sierrasil (2 g/day), low dose sierrasil (2 g/day) + cat's claw extract (100 mg/day) or placebo, administered for 8 weeks. Treatment was double blinded. Primary efficacy variables were WOMAC scores (A, B, C and total). Visual analog score (VAS) for pain, consumption of rescue medication (paracetamol), and tolerability were secondary variables. Safety measures included vital signs and laboratory-based assays. RESULTS: Ninety-one of the 107 patients successfully completed the protocol. All four groups showed improvement in WOMAC and VAS scores after 8 weeks (p < 0.001), in all 3 groups receiving sierrasil the magnitude of benefits were greater vs. placebo (WOMAC Total 38–43% vs. 27%) but this was not statistically significant. In reference to baseline values sierrasil treated groups had a considerably faster onset of benefits. Placebo-treated individuals failed to show significant benefits at 4 weeks (11% reduction in total WOMAC). In contrast, after 1 or 2 weeks of therapy all the sierrasil groups displayed significant reductions in WOMAC scores (p < 0.05) and at week 4 displayed a 38–43% improvement. VAS was significantly improved at 4 weeks in all groups (p < 0.001) but was significantly greater in all sierrasil groups compared to placebo (p < 0.05). Rescue medication use was 28-23% lower in the herbomineral combination and high dose sierrasil groups although not statistically different from placebo (P = 0.101 and P = 0.193, respectively). Tolerability was good for all groups, no serious adverse events were noted and safety parameters remained unchanged. CONCLUSION: The natural mineral supplement, sierrasil alone and in combination with a cat's claw extract, improved joint health and function within 1–2 weeks of treatment but significant benefits over placebo were not sustained, possibly due to rescue medication masking. Sierrasil may offer an alternative therapy in subjects with joint pain and dysfunction. BioMed Central 2005-10-21 /pmc/articles/PMC1276811/ /pubmed/16242032 http://dx.doi.org/10.1186/1476-9255-2-11 Text en Copyright © 2005 Miller et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Miller, Mark JS
Mehta, Komal
Kunte, Sameer
Raut, Vidyanand
Gala, Jayesh
Dhumale, Ramesh
Shukla, Anil
Tupalli, Hemant
Parikh, Himanshu
Bobrowski, Paul
Chaudhary, Jayesh
Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]
title Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]
title_full Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]
title_fullStr Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]
title_full_unstemmed Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]
title_short Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized controlled trial [ISRCTN38432711]
title_sort early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [isrctn38432711]
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1276811/
https://www.ncbi.nlm.nih.gov/pubmed/16242032
http://dx.doi.org/10.1186/1476-9255-2-11
work_keys_str_mv AT millermarkjs earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT mehtakomal earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT kuntesameer earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT rautvidyanand earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT galajayesh earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT dhumaleramesh earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT shuklaanil earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT tupallihemant earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT parikhhimanshu earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT bobrowskipaul earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711
AT chaudharyjayesh earlyreliefofosteoarthritissymptomswithanaturalmineralsupplementandaherbomineralcombinationarandomizedcontrolledtrialisrctn38432711